Project Grant R03TR004310
Award Date
9/1/23
Completion Date
8/31/25
Dollars Obligated
$153K
Federal Agency
National Center for Advancing Translational Sciences
Federal Grant Program
93.350
Assistance Type
Project Grant
Place of Performance
Lexington, KY 40526, USA
Similar Awards
The University of Kentucky Research Foundation has received a $2,061,903 Project Grant award from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct a 4-year research project titled "Novel Calcitropes as Targets for Cardiomyopathy Treatment". This award aims to support innovative biomedical research focused on developing new treatments for heart disease. The Research Foundation, a non-profit subsidiary of the University of...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $431,750 to a collaborative research partnership between Henry Ford Health and Michigan State University Health Sciences. The funding supports a project to overexpress the CYP2C11 enzyme in peri-lesion astrocytes of mice with multi-infarct dementia (MID), a prevalent vascular...
This federal Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) provides $758,744 to The University of Kentucky Research Foundation to conduct research aimed at understanding the mechanisms of blood-brain barrier dysfunction in Alzheimer's disease and developing therapeutic strategies to repair this dysfunction. The key objectives of the research are to: 1) Identify the signaling mechanisms by which the protein tau induces blood-brain barrier...
This federal Project Grant award, issued by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $4,693,249 to the University of California, Los Angeles (UCLA) to conduct research on defining the molecular spectrum of white matter vascular lesions that drive vascular cognitive impairment and dementia (VCID). The project aims to develop a better understanding of...
This $770,502 project grant awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research to understand the molecular mechanisms underlying cerebral small vessel disease (CSVD) and its relationship to vascular contributions to cognitive impairment and dementia (VCID). The research will utilize mouse models with COL4A1 and COL4A2 gene mutations, which are...
The University of Texas Health Science Center at Houston (UTHealth) received a $156,000 Project Grant award from the National Center for Advancing Translational Sciences (NCATS) under the NCATS Federal Grant Program (CFDA 93.350) to study the role of the SETD5 gene in the pathogenesis of Moyamoya disease, a leading cause of pediatric stroke. The research will focus on determining how loss-of-function variants in SETD5 impact smooth muscle cell differentiation, proliferation, and migration -...
This $1,120,805 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders federal grant program (CFDA 93.853), will support research to investigate how prior SARS-CoV-2 infection may increase the risk of vascular contributions to cognitive impairment and dementia (VCID). The research aims to: Determine how prior SARS-CoV-2 infection influences blood-brain barrier...
The University of Missouri System received a $234,750 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The purpose of this 2-year award, with a start date of June 1, 2025, is to investigate the role of cell adhesion molecules, such as integrin A5B1 and N-cadherin, in regulating cerebral artery myogenic tone and their potential...
The University of Missouri System was awarded a $392,026 Project Grant from the National Institute on Aging (CFDA 93.866 - Aging Research) to develop an innovative approach for treating Alzheimer's disease (AD). The key product being delivered is a novel therapeutic intervention that aims to systematically and sustainably elevate nicotinamide adenine dinucleotide (NAD+) levels in the body to counteract NAD+ decline associated with AD progression. The project will utilize a helper-dependent...
This federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $226,877 to Vanderbilt University to develop the first engineered human neurovascular unit (NVU) model capable of demonstrating neurovascular coupling (NVC). The goal is to model the glutamate-NMDA-nNOS-NO pathway in order to understand how neural activity triggers vasodilation, which is critical for cognitive function. The project aims to:...